88 related articles for article (PubMed ID: 12771525)
1. Treatment of a patient with advanced esophageal cancer with a combination of mitomycin C and capecitabine: activation of the thymidine phosphorylase as active principle?
Hofheinz RD; Weisser A; Willer A; Hehlmann R; Hochhaus A
Onkologie; 2003 Apr; 26(2):161-4. PubMed ID: 12771525
[TBL] [Abstract][Full Text] [Related]
2. EXTRA--a multicenter phase II study of chemoradiation using a 5 day per week oral regimen of capecitabine and intravenous mitomycin C in anal cancer.
Glynne-Jones R; Meadows H; Wan S; Gollins S; Leslie M; Levine E; McDonald AC; Myint S; Samuel L; Sebag-Montefiore D;
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):119-26. PubMed ID: 18472366
[TBL] [Abstract][Full Text] [Related]
3. A phase II study of capecitabine and cisplatin (XP) as first-line chemotherapy in patients with advanced esophageal squamous cell carcinoma.
Lee J; Im YH; Cho EY; Hong YS; Lee HR; Kim HS; Kim MJ; Kim K; Kang WK; Park K; Shim YM
Cancer Chemother Pharmacol; 2008 Jun; 62(1):77-84. PubMed ID: 17762932
[TBL] [Abstract][Full Text] [Related]
4. A phase I dose escalation study of a pharmacobiologically based scheduling of capecitabine and mitomycin C in patients with gastrointestinal malignancies.
Bekaii-Saab T; Hill M; Campbell A; Kosuri K; Thomas J; Villalona-Calero M
Cancer Chemother Pharmacol; 2010 Apr; 65(5):863-9. PubMed ID: 19657639
[TBL] [Abstract][Full Text] [Related]
5. Mitomycin-C and capecitabine as third-line chemotherapy in patients with advanced colorectal cancer: a phase II study.
Lim DH; Park YS; Park BB; Ji SH; Lee J; Park KW; Kang JH; Lee SH; Park JO; Kim K; Kim WS; Jung CW; Im YH; Kang WK; Park K
Cancer Chemother Pharmacol; 2005 Jul; 56(1):10-4. PubMed ID: 15782313
[TBL] [Abstract][Full Text] [Related]
6. Mitomycin C and capecitabine combination (MiXe) in heavily pretreated metastatic breast cancer patients. A dose-finding study.
Maisano R; Caristi N; Mare M; Mafodda A; Carboni R; Montalto E; Iorfida M; Nardi M
Anticancer Res; 2005; 25(6C):4513-7. PubMed ID: 16334135
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of thymidine phosphorylase in rectal cancer tissues by mitomycin C.
Ogata Y; Matono K; Sasatomi T; Ishibashi N; Torigoe S; Fukumitsu T; Mizobe T; Yamashita N; Yanagawa T; Shirouzu K
J Surg Oncol; 2006 Jan; 93(1):47-55. PubMed ID: 16353181
[TBL] [Abstract][Full Text] [Related]
8. Thymidine synthase, thymidine phosphorylase, and excision repair cross-complementation group 1 expression as predictive markers of capecitabine plus cisplatin chemotherapy as first-line treatment for patients with advanced oesophageal squamous cell carcinoma.
Lee S; Park YH; Kim KH; Cho EY; Ahn YC; Kim K; Shim YM; Ahn JS; Park K; Im YH
Br J Cancer; 2010 Sep; 103(6):845-51. PubMed ID: 20700125
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of capecitabine in combination with docetaxel and mitomycin C in patients with pre-treated pancreatic, gallbladder, and bile duct carcinoma.
Kruth J; Nissen J; Ernst T; Kripp M; Lukan N; Merx K; Hofmann WK; Hochhaus A; Hofheinz RD
J Cancer Res Clin Oncol; 2010 Dec; 136(12):1845-51. PubMed ID: 20224968
[TBL] [Abstract][Full Text] [Related]
10. Simultaneous integrated boost-intensity modulated radiation therapy with concomitant capecitabine and mitomycin C for locally advanced anal carcinoma: a phase 1 study.
Deenen MJ; Dewit L; Boot H; Beijnen JH; Schellens JH; Cats A
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):e201-7. PubMed ID: 23517808
[TBL] [Abstract][Full Text] [Related]
11. Combination of capecitabine and mitomycin C as first-line treatment in patients with metastatic breast cancer.
Vrdoljak E; Boban M; Omrcen T; Hrepic D; Fridl-Vidas V; Boskovic L
Neoplasma; 2011; 58(2):172-8. PubMed ID: 21275468
[TBL] [Abstract][Full Text] [Related]
12. Mitomycin C in combination with capecitabine or biweekly high-dose gemcitabine in patients with advanced biliary tract cancer: a randomised phase II trial.
Kornek GV; Schuell B; Laengle F; Gruenberger T; Penz M; Karall K; Depisch D; Lang F; Scheithauer W
Ann Oncol; 2004 Mar; 15(3):478-83. PubMed ID: 14998852
[TBL] [Abstract][Full Text] [Related]
13. Schedule dependency of antitumor activity in combination therapy with capecitabine/5'-deoxy-5-fluorouridine and docetaxel in breast cancer models.
Fujimoto-Ouchi K; Tanaka Y; Tominaga T
Clin Cancer Res; 2001 Apr; 7(4):1079-86. PubMed ID: 11309360
[TBL] [Abstract][Full Text] [Related]
14. Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials.
Ntukidem N; Arce-Lara C; Otterson GA; Kraut E; Cataland S; Bekaii-Saab T
Cancer Chemother Pharmacol; 2010 Jan; 65(2):319-24. PubMed ID: 19506871
[TBL] [Abstract][Full Text] [Related]
15. Outcomes from chemoradiotherapy for patients with esophageal cancer.
Pantling AZ; Gossage JA; Mamidanna R; Newman G; Robinson A; Manifold DK; Hale PC
Dis Esophagus; 2011 Apr; 24(3):172-6. PubMed ID: 21073614
[TBL] [Abstract][Full Text] [Related]
16. Mitomycin C plus capecitabine (mixe) in anthracycline- and taxane-pretreated metastatic breast cancer. A multicenter phase II study.
Maisano R; Caristi N; Mare M; Raffaele M; Iorfida M; Mafodda A; Zavettieri M; Nardi M
Anticancer Res; 2007; 27(4C):2871-5. PubMed ID: 17695463
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiotherapy with capecitabine for locally advanced anal carcinoma: an alternative treatment option.
Meulendijks D; Dewit L; Tomasoa NB; van Tinteren H; Beijnen JH; Schellens JH; Cats A
Br J Cancer; 2014 Oct; 111(9):1726-33. PubMed ID: 25167226
[TBL] [Abstract][Full Text] [Related]
18. Definitive chemoradiotherapy with capecitabine and cisplatin for elder patients with locally advanced squamous cell esophageal cancer.
Xing L; Liang Y; Zhang J; Wu P; Xu D; Liu F; Yu X; Jiang Z; Song X; Zang Q; Wang W
J Cancer Res Clin Oncol; 2014 May; 140(5):867-72. PubMed ID: 24578238
[TBL] [Abstract][Full Text] [Related]
19. Capecitabine and mitomycin C is an effective combination for anthracycline- and taxane-resistant metastatic breast cancer.
Massacesi C; La Cesa A; Marcucci F; Pilone A; Rocchi MB; Zepponi L; Santini D; Tonini G; Burattini L
Oncology; 2006; 70(4):294-300. PubMed ID: 17047400
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial.
Hofheinz RD; Hartmann JT; Willer A; Oechsle K; Hartung G; Gnad U; Saussele S; Kreil S; Bokemeyer C; Hehlmann R; Hochhaus A
Br J Cancer; 2004 Aug; 91(5):834-8. PubMed ID: 15238990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
